Now ideas for wellness

About Meiji
At a Glance

At a Glance

Get to know Meiji at a glance – from our core business to our most important numbers.

CLOSE

Food
Our Nutrition Initiatives

Our Nutrition Initiatives

Our goal is to improve the lives of people of all ages around the world through nutrition, from infants to older adults, and we are dedicated to achieving this goal.

CLOSE

Pharmaceuticals

R&D

Medical needs are always diversifying – here's how Meiji is responding.

CLOSE

Sustainability

Search Documents

Download the Meiji Group’s sustainability reports and ESG data.

CLOSE

Investors

Invest in Meiji

Meiji delivers long-term growth and stakeholder returns – here’s how we do it.

CLOSE
Search this site

M&A and Alliances

As of March, 2024

Completed Acquisitions

Name of Acquirer Name of Acquiree Date of Acquisition Business
Meiji Seika Pharma Co., Ltd. Medreich Ltd. (India) Jun 2014 Contract manufacturing organization/
contract development and manufacturing organization
business and manufacturing and sale of pharmaceutical products
Meiji Holdings Co., Ltd.
Meiji Seika Pharma Co., Ltd.		 KM Biologics Co., Ltd. (Japan) July 2018 Research development, manufacturing and supply of biological pharmaceuticals such as vaccines and blood plasma products
Meiji Co., Ltd. AUSTASIA GROUP PTE. LTD. (Singapore) July 2020 Procuring a stable and high quality raw milk supply

Joint Ventures

Meiji Group Licensee Alliance Partners Date Initiated Agreements
Meiji Seika Pharma Co., Ltd. Tjipto Pusposuharto and others (Indonesia) Mar 1974 Manufacturing and sales of
antibiotics and other pharmaceuticals
Nana Chart Traders Consolidation Ltd. and others (Thailand) Sep 1979 Manufacturing and sales of
antibiotics and other pharmaceuticals
Meiji Co., Ltd Bangkok IN-EX Co., Ltd.
Charoen Pokphand Group Co., Ltd. (Thailand)		 Jan 1989 Commercialization partnership of
drinking milk, yogurt and others in Thailand

Business Collaboration Agreements

Meiji Group Licensee Alliance Partners Date Initiated Agreements
Meiji Seika Pharma Co., Ltd. Taiho Pharmaceutical Co., Ltd. Dec 2015 Co-marketing Agreement in Japan for bilastine
Meiji Seika Pharma Co., Ltd. Seqirus Inc. (USA) Jan 2024* Licensable material is not limited to ARCT-154; it also encompasses future variant specific products, and other multi-strain products, such as bivalent vaccines. Rights for development within Japan have been acquired.

* Some terms of the agreement concluded in April 2023 were amended, and the parties re-entered into an agreement in January 2024.

Technical Alliances

In-Licensing
Meiji Group Licensee Alliance Partners Date Initiated Agreements
Meiji Co., Ltd. LB Bulgaricum
(Republic of Bulgaria)		 May 2000 Licensing Agreement on Technical Assistance
Meiji Seika Pharma Co., Ltd. Organon & Co. (USA) Mar 2013 Commercialization
partnership of Asenapine

On this site, we use cookies to provide better service to our customers. By accessing this site, you agree to our use of cookies. For more details, please see Terms and Conditions.

Accept